Results 111 to 120 of about 25,524 (191)

PBPK Modeling of CES1-Activated Prodrugs Across Different Age Groups: Simultaneous Prodrug-Metabolite Prediction for Oseltamivir, Enalapril, and Cilazapril. [PDF]

Pharmaceutics
Li P, Yang Y, Jiang L, Wang J.
europepmc   +1 more source

Antiviral Susceptibility of Clade 2.3.4.4b H5N1 and H5N5 Influenza Viruses Detected in Birds in Russia During 2021-2022. [PDF]

Viruses
Svyatchenko SV, Goncharova NI, Susloparov IM, Vasiltsova NN, Kolosova NP, Egorova ML, Tregubchak TV, Danilchenko NV, Ilyicheva TN, Marchenko VY.   +9 more
europepmc   +1 more source

Oseltamivir-Based Organic Salts and Ionic Liquids: Physicochemical Properties, Cytotoxicity, and Neuraminidase Inhibition. [PDF]

Pharmaceutics
Madeira DA, Correia V, Santos L, Rebelo-de-Andrade H, Branco LC.   +4 more
europepmc   +1 more source

Stability Study of a Frozen Oseltamivir 15 mg/mL Oral Solution in Amber Glass Bottles. [PDF]

Pharmaceutics
Ramirez JCR, Sáez AG, Madrid MEM, Viney AC, Herreros JMA, Rojo PA.   +5 more
europepmc   +1 more source

Oseltamivir-Associated Angioedema in a Patient Receiving Angiotensin-Converting Enzyme Inhibitor Therapy for Influenza A: A Case Report. [PDF]

Cureus
Dosumu OA.
europepmc   +1 more source

Emergence and spread of NA-I223V and NA-S247N double-mutant A(H1N1)pdm09 influenza viruses with reduced oseltamivir susceptibility in the Netherlands and beyond, 2023 to 2026. [PDF]

Euro Surveill
Felix Garza Z, Eggink D, Bagheri M, van den Brink S, Goderski G, Pronk M, Lexmond P, Hooiveld M, van Gageldonk-Lafeber R, Koel B, Fouchier R, Meijer A.   +11 more
europepmc   +1 more source

Antiviral Resistance Associated With Multiple Mutations Occurring in Seasonal Influenza A(H3N2) Virus in a Patient Treated With Oseltamivir. [PDF]

Clin Case Rep
Hussain S, Guo C, Deng YM, Deshpande N, Chanthalavanh P, Spirason N, Burmas L, Peck H, Gardiner BJ, Barr IG.   +9 more
europepmc   +1 more source

The association of empirical treatment with oseltamivir with the outcome of critically ill patients admitted with severe acute respiratory illness (SARI). [PDF]

SAGE Open Med
Khan RM, AlMarashi LM, Temsah MH, Al Ghamdi GAA, Sadat M, Bin Humaid F, Jose J, Al-Hameed F, Al Khatib K, AlObaidi M, Alanezi MS, Al-Basseet FF, Alanazi R, Arabi Y.   +13 more
europepmc   +1 more source

Oseltamivir for Treatment of Influenza Among Outpatient Veterans: Target Trial Emulation. [PDF]

Open Forum Infect Dis
Yan L, Li Y, Vergun R, Rajeevan N, Berry K, Mutalik P, Anderson K, Vales J, Hynes DM, Bui DP, Lin HM, Huang Y, Aslan M, Ioannou GN, Bajema KL.   +14 more
europepmc   +1 more source

Baloxavir marboxil versus oseltamivir for influenza A in children aged 5 years and older: a community-based prospective cohort study. [PDF]

BMC Infect Dis
Li W, Zhou M, Ye H, Liu L, Yan J.
europepmc   +1 more source